Aurion Biotech Announces First Subject Dosed in U.S. Phase 1 / 2 Clinical Trial
Allogeneic Cell Therapy for the Treatment of Corneal Edema Secondary to Corneal Endothelial Dysfunction SEATTLE…
Allogeneic Cell Therapy for the Treatment of Corneal Edema Secondary to Corneal Endothelial Dysfunction SEATTLE…
Combines a high margin data center protection and application security service offering with low cost…
TEL AVIV, Israel, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a leading provider…
HONG KONG--(BUSINESS WIRE)--An annual outdoor sports gala, the “Sun Hung Kai Properties Hong Kong Cyclothonâ€,…
GUANGZHOU, China--(BUSINESS WIRE)--Show China's beauty industry to the world! — On the morning of 18…
Openings in Singapore and Geneva provide on-the-ground Pantheon expertise to meet growing demand in private…
Novel Setting in Tokyo’s Bustling Business District Looks to Maximize Convenience, Reach New Patients with…
SHENZHEN, China--(BUSINESS WIRE)--#CommunicationSolutions--Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and…
TAIPEI, Taiwan--(BUSINESS WIRE)--Autonomous mobile robots (AMR), which combine autonomous positioning and navigation, are a type…
HANOI, Vietnam--(BUSINESS WIRE)--#AI--FPT, global technology firm headquartered in Vietnam, and Landing AI, the US's leading…